Articles
DOP69 Ozanimod for induction treatment of Moderate-to-Severe Ulcerative Colitis: Results from a systematic literature review and network meta-analyses
- Journal/Conference:
- Journal of Crohn's and Colitis
- Author(s):
- Eaton, K., Duperrouzel, C., Bhandari, P., Craigie, S., Bonner, A., Cameron, C., Tencer, T., Kumar, J.
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Urinary
- Condition:
- Ulcerative Colitis
Ozanimod for treatment of biologic-experienced patients with moderate-to-severe ulcerative colitis: Results from a systematic literature review and network meta-analyses
- Journal/Conference:
- ISPOR EU 2021
- Author(s):
- Eaton, K.; Duperrouzel, C.; Bhandari, P.; Craigie, S.; Bonner, A.; Cameron, C.; Tencer, T.; Kumar, J.
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Digestive
- Condition:
- Ulcerative Colitis
Systematic Literature Reviews (SLRS) of Economic Evaluations and Health Utility Studies of AML Treatments for Adults Receiving High Intensity Induction Therapy, with or without Maintenance Therapy
- Journal/Conference:
- ISPOR EU 2021
- Author(s):
- Ahmed, M.; Suero, S.; Cameron, H.; Chen, C.
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Oncology
- Condition:
- AML
Systematic Literature Review of the Efficacy and Safety of Maintenance Therapies for Adults with Acute Myeloid Leukemia in Complete Remission who are Ineligible for Hematopoetic Stem Cell Transplant
- Journal/Conference:
- European Hematology Association Annual Meeting
- Author(s):
- Suero B, Cameron H, Thompson G, Ahmed M, Chen C
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Oncology
- Condition:
- AML
European Guidelines and Real-World Evidence of Maintenance Treatments for Adults with Acute Myeloid Leukemia in First Complete Remission.
- Journal/Conference:
- European Hematology Association Annual Meeting
- Author(s):
- Ahmed M, Thompson G, Martin C, Cameron H, Chen C
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Oncology
- Condition:
- AML
Matching Adjusted Indirect Comparison (MAIC) of Oral Azacitidine (Oral-AZA) Versus Injectable AZA in Patients (pts) with Acute Myeloid Leukemia (AML) in First Remission after Intensive Induction Chemotherapy.
- Journal/Conference:
- Blood 138 (Supplement 1): 3015
- Author(s):
- Chen, C.; Huls, GA.; Cameron, H.; Suero, B.; Vasconcelos A.; Gaugler, L.; Beach, C.L.
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Oncology
- Condition:
- AML
A comparison of the costs of atrial fibrillation ablation using radiofrequency and cryoballoon technologies in the United Kingdom and Italy
- Journal/Conference:
- ISPOR EU 2021
- Author(s):
- Stabile G, Wei T, Taylor H, Velleca M, Ivanova IA, Dineen A, Patel L
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Cardiac
- Condition:
- Atrial Fibrillation
A Scorecard for Osteoporosis in Canada and Seven Canadian Provinces.
- Journal/Conference:
- Osteoporosis International
- Author(s):
- DL Kendler, JD Adachi, JP Brown, AG Juby, CS Kovacs, C Duperrouzel, RK McTavish, C Cameron, L Slatkovska, N Burke
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Skeletal
- Condition:
- Osteoporosis
Oncology drugs without Phase III data: Comparison of reimbursement recommendations issued by the Canadian Agency for Drugs and Technologies in Health (CADTH), and the National Institute for Health and Care Excellence (NICE)
- Journal/Conference:
- ISPOR EU 2021
- Author(s):
- Singh, S.; Hachborn, G.
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Oncology
- Condition:
- Cancer
Hospital Costs Associated with Cataract, Glaucoma, Vitreoretinal, and Laser Refractive Surgeries in Europe: A Comprehensive Literature Review
- Journal/Conference:
- ISPOR EU 2021
- Author(s):
- Hang, C.; Duperrouzel, C.; Zhou, A.
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Vision
- Condition:
- Eye